US M&A and equity raisings

3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

3 deals · US$8.8bndisclosed · Radiopharmaceuticals · Clear

Columns
US M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Aug 2026 Lantheus Holdings –Curium US HoldingsAcquisitionAnnounced8,000.0Radiopharmaceuticals+1 Morgan Stanley (sell-side)BofA Securities (sell-side)Solomon Partners (sell-side)Covington & Burling (sell-side)Ropes & Gray (sell-side)Jefferies (buy-side)J.P. Morgan (buy-side)PJT Partners (buy-side)Kirkland & Ellis (buy-side)Arnold & Porter (buy-side)
Aug 2026 BWXT Medical business BWX TechnologiesNordic CapitalAsset salePending800.0Radiopharmaceuticals+2 Solomon Partners (sell-side)Stikeman Elliott (sell-side)Kirkland & Ellis (buy-side)McCarthy Tétrault (buy-side)
Jan 2026 Lantheus SPECT business LantheusSHINE TechnologiesAsset saleAnnounced–Pharma+2 Solomon Partners (sell-side)

Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built